Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Existe información en español para pacientes y cuidadores, para acceder, haga clic sobre “Select” al lado de “I am a U.S. Patient / Caregiver”.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

bortezomib injection 3.5 MG VIAL Principal Display Panel (bortezomib for injection)

PRINCIPAL DISPLAY PANEL - 3.5 mg Vial Label

NDC 0409-1700-01

Bortezomib
for Injection

3.5 mg/vial

DISCARD UNUSED PORTION

FOR INTRAVENOUS OR
SUBCUTANEOUS USE

SINGLE USE VIAL

Rx ONLY
Hospira

PRINCIPAL DISPLAY PANEL - 3.5 mg Vial Label

PRINCIPAL DISPLAY PANEL - 3.5 mg Vial Carton

NDC 0409-1700-01

Bortezomib
for Injection

3.5 mg/vial

Reconstitution Information

SUBCUTANEOUS
INJECTION ONLY

Add 1.4 mL
0.9% Sodium
Chloride

To make 2.5 mg / mL
final concentration

INTRAVENOUS
INJECTION ONLY

Add 3.5 mL
0.9% Sodium
Chloride

To make 1 mg / mL
final concentration

Rx ONLY

Hospira

PRINCIPAL DISPLAY PANEL - 3.5 mg Vial Carton
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event